Author

William Hampton Bradley

Medical College of WisconsinORCID 0000-0002-6949-5262Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Akinyemi I. OjesinaiD· 2 shared Ishaque Pulikkal Kadamberi· 2 shared Janet Sue RaderiD· 2 shared A. Nair· 1 shared Ajay Nair· 1 shared Anjali GeethadeviiD· 1 shared Bakhtiyor NosiroviD· 1 shared Beth Erickson· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Akinyemi I. OjesinaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

TAOK3 inhibition constrains invasion, potentiates paclitaxel, and reprograms the tumor microenvironment toward anti-tumor immunity in cervical cancer

Marissa Iden, Rachel Schmidt, Rameesa Darul Amne Syed Mohammed, Theresa A. Dlugi, Rajeswary Kumar, Shirng‐Wern Tsaih, Bakhtiyor Nosirov, Ishaque Pulikkal Kadamberi, Sonam Mittal, Shruti L Narayan, William Hampton Bradley, Beth Erickson, Rebecca C. Czaja, Juan Carlos Felix, Victor X. Jin, , Janet Sue Rader

This study shows TAOK3 inhibition reduces cervical cancer invasion, increases paclitaxel sensitivity, and promotes anti-tumor immunity by altering the tumor microenvironment.

bioRxiv · Jul 6, 2026 · PreprintCancer Biology

MRPL47 as a Novel Mitochondrial Biomarker for Early Detection and Therapeutic Response in Ovarian Cancer

Meenakshi Pradeep, Ishaque Pulikkal Kadamberi, Jasmine George, Yueying Gao, Camilla Dagum, Ajay Nair, Shirng-Wern Tsaih, Anjali Geethadevi, A. Nair, Elizabeth E. Hopp, Denise S. Uyar, William Hampton Bradley, Janet Sue Rader, Yongsheng Li, Pradeep Chaluvally–Raghavan, Akinyemi I. Ojesina

This study identifies MRPL47 as a biomarker for ovarian cancer, showing its association with poor survival, metabolic changes, and therapeutic response.

bioRxiv · Mar 9, 2026 · PreprintCancer Biology